Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 13980 | 800 | 29.3 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
| 464 | 3 | APPENDICITIS//DIVERTICULITIS//INTRAPERITONEAL CHEMOTHERAPY | 24402 |
| 1258 | 2 | APPENDICITIS//INTRAPERITONEAL CHEMOTHERAPY//APPENDIX | 8852 |
| 13980 | 1 | INTRAPERITONEAL CHEMOTHERAPY//INTRAPERITONEAL THERAPY//INTRAPERITONEAL | 800 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | INTRAPERITONEAL CHEMOTHERAPY | authKW | 1267706 | 17% | 24% | 137 |
| 2 | INTRAPERITONEAL THERAPY | authKW | 281032 | 2% | 41% | 18 |
| 3 | INTRAPERITONEAL | authKW | 256312 | 6% | 15% | 46 |
| 4 | INTRAPERITONEAL CATHETER | authKW | 159031 | 1% | 83% | 5 |
| 5 | FLUID OSMOLARITY | authKW | 152671 | 1% | 100% | 4 |
| 6 | IP CHEMOTHERAPY | authKW | 85876 | 0% | 75% | 3 |
| 7 | OVARIAN CANCER | authKW | 85522 | 20% | 1% | 162 |
| 8 | 8C2 | authKW | 76336 | 0% | 100% | 2 |
| 9 | INTRAPERITONEAL CARBOPLATIN | authKW | 76336 | 0% | 100% | 2 |
| 10 | IP CATHETER | authKW | 76336 | 0% | 100% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 15570 | 71% | 0% | 568 |
| 2 | Obstetrics & Gynecology | 6301 | 27% | 0% | 217 |
| 3 | Pharmacology & Pharmacy | 253 | 13% | 0% | 102 |
| 4 | Medicine, Research & Experimental | 23 | 3% | 0% | 26 |
| 5 | CYTOLOGY & HISTOLOGY | 17 | 0% | 0% | 2 |
| 6 | Medicine, General & Internal | 14 | 4% | 0% | 30 |
| 7 | Surgery | 13 | 5% | 0% | 37 |
| 8 | Radiology, Nuclear Medicine & Medical Imaging | 10 | 3% | 0% | 22 |
| 9 | Hematology | 9 | 2% | 0% | 15 |
| 10 | Nursing | 7 | 1% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANTONI VAN LEEUWENHOEK ZIEKENHUIS PLESMANLAAN 121 | 38168 | 0% | 100% | 1 |
| 2 | BIOL EVALUAT SHARED OURCE | 38168 | 0% | 100% | 1 |
| 3 | BT 506 | 38168 | 0% | 100% | 1 |
| 4 | CANC CHEMOPROPHYLAXIS ONCOPHARMACOL | 38168 | 0% | 100% | 1 |
| 5 | CHAIR GYNAECOL SURG GYNAECOL ONCOL ADULT | 38168 | 0% | 100% | 1 |
| 6 | CLEVELAND CLIN TAUSSIG CANC R30 | 38168 | 0% | 100% | 1 |
| 7 | DIAG CANC THER Y EVALUAT PROGRAM | 38168 | 0% | 100% | 1 |
| 8 | DYNECOL DIS MANAGEMENT TEAM | 38168 | 0% | 100% | 1 |
| 9 | GF LECLERC REG ANTICANC | 38168 | 0% | 100% | 1 |
| 10 | GRP BIOL THER IE CANC JE MENRT 515 | 38168 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | GYNECOLOGIC ONCOLOGY | 42197 | 14% | 1% | 112 |
| 2 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 16578 | 6% | 1% | 44 |
| 3 | CANCER DRUG DELIVERY | 16109 | 1% | 6% | 7 |
| 4 | SEMINARS IN ONCOLOGY | 9469 | 5% | 1% | 36 |
| 5 | JOURNAL OF CLINICAL ONCOLOGY | 4112 | 5% | 0% | 42 |
| 6 | CANCER TREATMENT REPORTS | 3373 | 2% | 1% | 14 |
| 7 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2719 | 3% | 0% | 23 |
| 8 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1835 | 2% | 0% | 14 |
| 9 | ACTA MEDICA AUSTRIACA | 1149 | 1% | 1% | 5 |
| 10 | BULLETIN DU CANCER | 1080 | 1% | 0% | 11 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | INTRAPERITONEAL CHEMOTHERAPY | 1267706 | 17% | 24% | 137 | Search INTRAPERITONEAL+CHEMOTHERAPY | Search INTRAPERITONEAL+CHEMOTHERAPY |
| 2 | INTRAPERITONEAL THERAPY | 281032 | 2% | 41% | 18 | Search INTRAPERITONEAL+THERAPY | Search INTRAPERITONEAL+THERAPY |
| 3 | INTRAPERITONEAL | 256312 | 6% | 15% | 46 | Search INTRAPERITONEAL | Search INTRAPERITONEAL |
| 4 | INTRAPERITONEAL CATHETER | 159031 | 1% | 83% | 5 | Search INTRAPERITONEAL+CATHETER | Search INTRAPERITONEAL+CATHETER |
| 5 | FLUID OSMOLARITY | 152671 | 1% | 100% | 4 | Search FLUID+OSMOLARITY | Search FLUID+OSMOLARITY |
| 6 | IP CHEMOTHERAPY | 85876 | 0% | 75% | 3 | Search IP+CHEMOTHERAPY | Search IP+CHEMOTHERAPY |
| 7 | OVARIAN CANCER | 85522 | 20% | 1% | 162 | Search OVARIAN+CANCER | Search OVARIAN+CANCER |
| 8 | 8C2 | 76336 | 0% | 100% | 2 | Search 8C2 | Search 8C2 |
| 9 | INTRAPERITONEAL CARBOPLATIN | 76336 | 0% | 100% | 2 | Search INTRAPERITONEAL+CARBOPLATIN | Search INTRAPERITONEAL+CARBOPLATIN |
| 10 | IP CATHETER | 76336 | 0% | 100% | 2 | Search IP+CATHETER | Search IP+CATHETER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | GADDUCCI, A , CONTE, PF , (2008) INTRAPERITONEAL CHEMOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER: A CRITICAL REVIEW OF THE LITERATURE.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. VOL. 18. ISSUE 5. P. 943-953 | 79 | 91% | 14 |
| 2 | HAMILTON, CA , BEREK, JS , (2006) INTRAPERITONEAL CHEMOTHERAPY FOR OVARIAN CANCER.CURRENT OPINION IN ONCOLOGY. VOL. 18. ISSUE 5. P. 507 -515 | 68 | 89% | 8 |
| 3 | HASOVITS, C , CLARKE, S , (2012) PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAPERITONEAL CANCER CHEMOTHERAPEUTICS.CLINICAL PHARMACOKINETICS. VOL. 51. ISSUE 4. P. 203 -224 | 86 | 55% | 18 |
| 4 | FUJIWARA, K , ARMSTRONG, D , MORGAN, M , MARKMAN, M , (2007) PRINCIPLES AND PRACTICE OF INTRAPERITONEAL CHEMOTHERAPY FOR OVARIAN CANCER.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. VOL. 17. ISSUE 1. P. 1-20 | 53 | 80% | 33 |
| 5 | HOFSTRA, LS , DE VRIES, EGE , MULDER, NH , WILLEMSE, PHB , (2000) INTRAPERITONEAL CHEMOTHERAPY IN OVARIAN CANCER.CANCER TREATMENT REVIEWS. VOL. 26. ISSUE 2. P. 133 -143 | 60 | 78% | 21 |
| 6 | HELM, CW , (2012) PORTS AND COMPLICATIONS FOR INTRAPERITONEAL CHEMOTHERAPY DELIVERY.BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. VOL. 119. ISSUE 2. P. 150 -159 | 31 | 100% | 10 |
| 7 | GONZALEZ, MJE , GREEN, R , MUGGIA, FM , (2011) INTRAPERITONEAL DRUG DELIVERY FOR OVARIAN CANCER: WHY, HOW, WHO, WHAT, AND WHEN?.ONCOLOGY-NEW YORK. VOL. 25. ISSUE 2. P. 156-170 | 30 | 86% | 10 |
| 8 | TUMMALA, MK , ALAGARSAMY, S , MCGUIRE, WP , (2008) INTRAPERITONEAL CHEMOTHERAPY: STANDARD OF CARE FOR PATIENTS WITH MINIMAL RESIDUAL STAGE III OVARIAN CANCER?.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 8. ISSUE 7. P. 1135-1147 | 34 | 76% | 4 |
| 9 | HESS, LM , ALBERTS, DS , (2007) THE ROLE OF INTRAPERITONEAL THERAPY IN ADVANCED OVARIAN CANCER.ONCOLOGY-NEW YORK. VOL. 21. ISSUE 2. P. 227 -232 | 31 | 78% | 4 |
| 10 | MARKMAN, M , (2003) INTRAPERITONEAL ANTINEOPLASTIC DRUG DELIVERY: RATIONALE AND RESULTS.LANCET ONCOLOGY. VOL. 4. ISSUE 5. P. 277-283 | 36 | 65% | 96 |
Classes with closest relation at Level 1 |